Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Novo Nordisk A/S’s Ozempic helped reduce alcohol cravings in a small study, more evidence that the popular injections may ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

initially receiving B12 injections that she ordered and also ordered two Ozempic pens in 2021 and another pen in May 2022. The prosecution told the jury that other prescriptions for Ozempic pens ...

Semaglutide — the powerful ingredient behind Wegovy and Ozempic — has long been ... Their semaglutide dose was set to 0.25mg per week for the first four weeks — the smallest dose available ...